Analysed ARTELO BIOSCIENCES INC (ARTL:NASDAQ) News Sources
Artelo Announces Third-Party Fully Funded Clinical Study Agreement to Evaluate ART27.13 in Glaucoma Patients
18-03-2026
yahoo.com
Artelo Biosciences Expands ART27.13 Development as a Potential Companion Therapy to GLP-1 Treatments
25-03-2026
yahoo.com
Artelo Biosciences Announces $11.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
27-03-2026
yahoo.com
Artelo Biosciences Announces Closing of $11.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
30-03-2026
yahoo.com
Artelo Announces Peer-Reviewed Publication Supporting its FABP5 Inhibitor ART26.12 as a Novel Pain Treatment with a Potentially First-in-Class Profile
20-04-2026
yahoo.com
Artelo Biosciences Announces Strategic Collaboration with Artificial Intelligence (AI) Leader ScienceMachine Highlighting New Expansion Opportunities and Insights for FABP5 Inhibitor Development
28-04-2026
yahoo.com
What is the current price of ARTELO BIOSCIENCES INC (ARTL:NASDAQ)?
The current price of ARTELO BIOSCIENCES INC (ARTL:NASDAQ) is $1.36.
ARTELO BIOSCIENCES INC (ARTL:NASDAQ) absolute price change since previous trading day?
The absolute price change of ARTELO BIOSCIENCES INC (ARTL:NASDAQ) since the previous trading day is $-0.35.
ARTELO BIOSCIENCES INC (ARTL:NASDAQ) percentage price change since previous trading day?
The percentage price change of ARTELO BIOSCIENCES INC (ARTL:NASDAQ) since the previous trading day is -20.4678%.
What is the most recent average sentiment score for ARTELO BIOSCIENCES INC (ARTL:NASDAQ)?
The most recent average sentiment score for ARTELO BIOSCIENCES INC (ARTL:NASDAQ) is 76 out of 100.
What is the most recent average sentiment for ARTELO BIOSCIENCES INC (ARTL:NASDAQ)?
The most recent sentiment for ARTELO BIOSCIENCES INC (ARTL:NASDAQ) is .
SEC-8K** Filing Available For ARTELO BIOSCIENCES INC (ARTL:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.